JP2022542140A5 - - Google Patents
Info
- Publication number
- JP2022542140A5 JP2022542140A5 JP2022505207A JP2022505207A JP2022542140A5 JP 2022542140 A5 JP2022542140 A5 JP 2022542140A5 JP 2022505207 A JP2022505207 A JP 2022505207A JP 2022505207 A JP2022505207 A JP 2022505207A JP 2022542140 A5 JP2022542140 A5 JP 2022542140A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025100363A JP2025134819A (ja) | 2019-07-24 | 2025-06-16 | 阻害剤化合物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2019902614 | 2019-07-24 | ||
| AU2019902614A AU2019902614A0 (en) | 2019-07-24 | Inhibitor compounds | |
| PCT/AU2020/050763 WO2021012018A1 (en) | 2019-07-24 | 2020-07-24 | Inhibitor compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025100363A Division JP2025134819A (ja) | 2019-07-24 | 2025-06-16 | 阻害剤化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022542140A JP2022542140A (ja) | 2022-09-29 |
| JP2022542140A5 true JP2022542140A5 (https=) | 2023-07-31 |
| JPWO2021012018A5 JPWO2021012018A5 (https=) | 2023-07-31 |
Family
ID=74192564
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022505207A Pending JP2022542140A (ja) | 2019-07-24 | 2020-07-24 | 阻害剤化合物 |
| JP2025100363A Pending JP2025134819A (ja) | 2019-07-24 | 2025-06-16 | 阻害剤化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025100363A Pending JP2025134819A (ja) | 2019-07-24 | 2025-06-16 | 阻害剤化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12448371B2 (https=) |
| EP (1) | EP4003986A4 (https=) |
| JP (2) | JP2022542140A (https=) |
| KR (1) | KR20220041843A (https=) |
| CN (1) | CN114450281B (https=) |
| AU (1) | AU2020316243A1 (https=) |
| BR (1) | BR112022001270A2 (https=) |
| CA (1) | CA3144506A1 (https=) |
| IL (1) | IL290087B1 (https=) |
| MX (1) | MX2022000845A (https=) |
| WO (1) | WO2021012018A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202213792D0 (en) * | 2022-09-21 | 2022-11-02 | Benevolentai Bio Ltd | New compounds and method |
| US11912675B1 (en) | 2023-10-11 | 2024-02-27 | King Faisal University | N'-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-3,4-dimethoxybenzimidamide as an antimicrobial compound |
| US11919872B1 (en) | 2023-10-11 | 2024-03-05 | King Faisal University | N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide as an antimicrobial compound |
| US11891366B1 (en) | 2023-10-12 | 2024-02-06 | King Faisal University | 4-methoxy-n′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide as an antimicrobial compound |
| US11999706B1 (en) | 2023-10-13 | 2024-06-04 | King Faisal University | 4-chloro-N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide as an antimicrobial compound |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2923661A (en) | 1957-03-22 | 1960-02-02 | Irwin Neisler And Co | N-[2-(1-phenyl-propyl)]-2, 2, 2-trichloroethylidenimine |
| US5684018A (en) | 1994-12-13 | 1997-11-04 | Merck & Co., Inc. | Acyloxyisopropyl carbamates as prodrugs for amine drugs |
| FI982268L (fi) | 1998-10-20 | 2000-04-21 | Tomi Jaervinen | Ei-steroidaalisten anti-inflammatoristen karboksyylihappojen uudet pro drugit, niiden valmistus ja käyttö |
| EP2162427A1 (en) * | 2007-05-22 | 2010-03-17 | Novartis Ag | Benzamides useful as s1p receptor modulators |
| WO2012164103A2 (en) | 2011-06-03 | 2012-12-06 | Universität Zürich | Blockers of the nogo-a s1pr pathway for the treatment of diseases characterized by neuronal damage and lack of subsequent repair |
| US20170165230A1 (en) * | 2014-04-09 | 2017-06-15 | Christopher Rudd | Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity |
| AU2015281799B2 (en) * | 2014-06-26 | 2019-11-28 | Central Adelaide Local Health Network Incorporated | Enzyme interacting agents |
| US11135207B2 (en) * | 2016-12-13 | 2021-10-05 | Centaurus Therapeutics | Inhibitors of dihydroceramide desaturase for treating disease |
| CN108079303A (zh) | 2017-12-14 | 2018-05-29 | 广东药科大学 | 鞘氨醇激酶抑制剂在制备治疗肝纤维化药物中的应用 |
-
2020
- 2020-07-24 CA CA3144506A patent/CA3144506A1/en active Pending
- 2020-07-24 AU AU2020316243A patent/AU2020316243A1/en active Pending
- 2020-07-24 WO PCT/AU2020/050763 patent/WO2021012018A1/en not_active Ceased
- 2020-07-24 BR BR112022001270A patent/BR112022001270A2/pt unknown
- 2020-07-24 MX MX2022000845A patent/MX2022000845A/es unknown
- 2020-07-24 US US17/629,218 patent/US12448371B2/en active Active
- 2020-07-24 CN CN202080066385.5A patent/CN114450281B/zh active Active
- 2020-07-24 JP JP2022505207A patent/JP2022542140A/ja active Pending
- 2020-07-24 KR KR1020227003262A patent/KR20220041843A/ko active Pending
- 2020-07-24 EP EP20843975.2A patent/EP4003986A4/en active Pending
-
2022
- 2022-01-24 IL IL290087A patent/IL290087B1/en unknown
-
2025
- 2025-06-16 JP JP2025100363A patent/JP2025134819A/ja active Pending
- 2025-09-08 US US19/322,461 patent/US20260001870A1/en active Pending